# New clinical trials in Belarus: 20 since Nov 2024

Updated November 12, 2026.

20 clinical studies with a site in Belarus were first posted on ClinicalTrials.gov from January 7, 2025 to November 12, 2026; 5 have an industry sponsor and 14 are recruiting or about to. The newest, NCT07931768, was posted on November 12, 2026: Perioperative Limb Oxygenation Monitoring in Patients With CLTI (Belarusian State Medical University).

## The full list

New clinical trials with a site in Belarus: 20 rows for $5, first posted on ClinicalTrials.gov from November 19, 2024 to November 18, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/country/belarus

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 20
- Industry sponsored: 5
- Recruiting or not yet: 14
- Latest posted: November 12, 2026

## Newest trials

The newest 20 of 20, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07931768 | Perioperative Limb Oxygenation Monitoring in Patients With CLTI | Belarusian State Medical University | Not applicable | Recruiting | Chronic Limb Threatening Ischemia, CLTI | 120 | Belarus | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931768) |
| August 3, 2026 | NCT07742215 | A Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma... | Biocad | Phase 3 | Recruiting | Myeloma Multiple | 390 | Belarus, Russia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07742215) |
| July 22, 2026 | NCT07720310 | Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus Erythematosus | N.N. Alexandrov National Cancer Centre | Observational | Enrolling by invitation | System Lupus Erythematosus(SLE) | 12 | Belarus | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07720310) |
| June 29, 2026 | NCT07673809 | A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therapy in Pediatric Patients With Duchenne Muscular Dystrophy | AO GENERIUM | Phase 1/2 | Recruiting | Duchenne Muscular Dystrophy | 32 | Belarus, Russia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07673809) |
| April 13, 2026 | NCT07524816 | Real World Practice With Academic Anti CD19 CAR-T Cell Therapy in Relapse/Refractory B-cell Lymphoma | N.N. Alexandrov National Cancer Centre | Observational | Recruiting | Large B-Cell Lymphoma (LBCL) | 76 | Belarus | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07524816) |
| March 17, 2026 | NCT07477912 | Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma | Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology | Phase 1/2 | Recruiting | Multiple Myeloma Refractory | 30 | Belarus | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07477912) |
| March 16, 2026 | NCT07472153 | PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or... | N.N. Alexandrov National Cancer Centre | Phase 2/3 | Recruiting | Metastatic Cervical Cancer, Persistent Cervical Cancer, Recurrent Cervical Cancer | 120 | Belarus | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07472153) |
| March 16, 2026 | NCT07472140 | PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian... | N.N. Alexandrov National Cancer Centre | Phase 2/3 | Recruiting | Ovarian Cancer, Fallopian Tube Cancers, Primary Peritoneal Cancer | 120 | Belarus | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07472140) |
| March 10, 2026 | NCT07460700 | Mesenteric Ischemia Markers Study | Belarusian State Medical University | Not applicable | Recruiting | Mesenteric Vascular Disease | 120 | Belarus | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07460700) |
| March 4, 2026 | NCT07448662 | Local Treatment Strategies for Brain Metastases of Colorectal Cancer | Blokhin's Russian Cancer Research Center | Observational | Active not recruiting | Colorectal Cancer, Brain Metastases, Adult | 700 | Belarus, Russia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07448662) |
| March 4, 2026 | NCT07448493 | Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer | Blokhin's Russian Cancer Research Center | Observational | Active not recruiting | Gastric Cancer, Esophageal Cancer, Brain Metastases | 230 | Belarus, Russia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07448493) |
| December 30, 2025 | NCT07308990 | Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Locally Advanced Prostate Cancer | N.N. Alexandrov National Cancer Centre | Not applicable | Recruiting | Prostate Cancer Patients Undergoing Radical Prostatectomy | 800 | Belarus | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07308990) |
| December 17, 2025 | NCT07288515 | Observ Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in Belarus | AstraZeneca | Observational | Recruiting | Chronic Lymphocytic Leukemia | 50 | Belarus | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07288515) |
| September 9, 2025 | NCT07162571 | This is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells... | Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology | Phase 1/2 | Enrolling by invitation | Acute Lymphobkastic Leukemia, B Cell Lymphoma | 17 | Belarus | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07162571) |
| September 8, 2025 | NCT07159698 | Clinical Profile of a Patient After MI and ACVA Based on Outpatient Register Data | State Institution "Republican Scientific and Practical Center" Cardiology, Belarus | Observational | Enrolling by invitation | Acute Cerebrovascular Accident, Myocardial Infarction (MI) | 1,520 | Belarus | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07159698) |
| August 7, 2025 | NCT07108309 | BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer | Biocad | Phase 2 | Recruiting | Triple Negative Breast Cancer | 124 | Belarus, Russia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07108309) |
| May 14, 2025 | NCT06971068 | Vacuum-assisted Laser Ablation (VALA) for Treatment of Large Saphenous Veins | Center Of Phlebology | Not applicable | Recruiting | Varicose Veins | 184 | Belarus, Kyrgyzstan, Russia, Uzbekistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06971068) |
| February 19, 2025 | NCT06835361 | Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal... | AVVA Pharmaceuticals Ltd. | Phase 2/3 | Recruiting | Candidal Vulvovaginitis (ICD-10 Code: B37.3), Vulvovaginal Candidiasis (VVC) | 264 | Belarus, Russia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06835361) |
| February 10, 2025 | NCT06815913 | To Develop and Introduce Into Polyclinic Practice a Register of Patients with Experience of Myocardial Infarction and Acute Cerebrovascular... | State Institution "Republican Scientific and Practical Center" Cardiology, Belarus | Observational | Active not recruiting | Myocardial Infarction (MI), Acute Cardiovascular Disease | 2,000 | Belarus | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06815913) |
| January 7, 2025 | NCT06762431 | Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and... | Vitebsk Regional Clinical Cancer Centre | Phase 1/2 | Recruiting | Chronic Lymphocytic Leukaemia (CLL), Small Lymphocytic Lymphoma (SLL) | 24 | Belarus | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06762431) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| N.N. Alexandrov National Cancer Centre | 5 | July 22, 2026 |
| Belarusian State Medical University | 2 | November 12, 2026 |
| Biocad | 2 | August 3, 2026 |
| Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology | 2 | March 17, 2026 |
| Blokhin's Russian Cancer Research Center | 2 | March 4, 2026 |
| State Institution "Republican Scientific and Practical Center" Cardiology, Belarus | 2 | September 8, 2025 |
| AO GENERIUM | 1 | June 29, 2026 |
| AstraZeneca | 1 | December 17, 2025 |
| Center Of Phlebology | 1 | May 14, 2025 |
| AVVA Pharmaceuticals Ltd. | 1 | February 19, 2025 |
| Vitebsk Regional Clinical Cancer Centre | 1 | January 7, 2025 |

## Conditions

| Condition group | New trials | Latest |
| --- | --- | --- |
| [Multiple Myeloma](https://specstream.ai/data/clinical-trials/condition/multiple-myeloma) | 2 | August 3, 2026 |
| [Brain Neoplasms](https://specstream.ai/data/clinical-trials/condition/brain-neoplasms) | 2 | March 4, 2026 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | December 17, 2025 |
| [Myocardial Infarction](https://specstream.ai/data/clinical-trials/condition/myocardial-infarction) | 2 | September 8, 2025 |
| Chronic Limb-Threatening Ischemia | 1 | November 12, 2026 |
| [Lupus Erythematosus, Systemic](https://specstream.ai/data/clinical-trials/condition/lupus-erythematosus-systemic) | 1 | July 22, 2026 |
| Muscular Dystrophy, Duchenne | 1 | June 29, 2026 |
| [Uterine Cervical Neoplasms](https://specstream.ai/data/clinical-trials/condition/uterine-cervical-neoplasms) | 1 | March 16, 2026 |
| [Ovarian Neoplasms](https://specstream.ai/data/clinical-trials/condition/ovarian-neoplasms) | 1 | March 16, 2026 |
| Fallopian Tube Neoplasms | 1 | March 16, 2026 |
| Mesenteric Ischemia | 1 | March 10, 2026 |
| [Colorectal Neoplasms](https://specstream.ai/data/clinical-trials/condition/colorectal-neoplasms) | 1 | March 4, 2026 |
| [Colonic Neoplasms](https://specstream.ai/data/clinical-trials/condition/colonic-neoplasms) | 1 | March 4, 2026 |
| [Rectal Neoplasms](https://specstream.ai/data/clinical-trials/condition/rectal-neoplasms) | 1 | March 4, 2026 |
| [Stomach Neoplasms](https://specstream.ai/data/clinical-trials/condition/stomach-neoplasms) | 1 | March 4, 2026 |
| [Esophageal Neoplasms](https://specstream.ai/data/clinical-trials/condition/esophageal-neoplasms) | 1 | March 4, 2026 |
| [Prostatic Neoplasms](https://specstream.ai/data/clinical-trials/condition/prostatic-neoplasms) | 1 | December 30, 2025 |
| Lymphoma, B-Cell | 1 | September 9, 2025 |
| [Stroke](https://specstream.ai/data/clinical-trials/condition/stroke) | 1 | September 8, 2025 |
| [Triple Negative Breast Neoplasms](https://specstream.ai/data/clinical-trials/condition/triple-negative-breast-neoplasms) | 1 | August 7, 2025 |
| Varicose Veins | 1 | May 14, 2025 |
| Candidiasis, Vulvovaginal | 1 | February 19, 2025 |
| Noncommunicable Diseases | 1 | February 10, 2025 |
| [Cardiovascular Diseases](https://specstream.ai/data/clinical-trials/condition/cardiovascular-diseases) | 1 | February 10, 2025 |
| Leukemia, B-Cell | 1 | January 7, 2025 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 7 | July 22, 2026 |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 4 | November 12, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 4 | June 29, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 3 | March 16, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 1 | August 3, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 1 | August 7, 2025 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B medical support companies in the United States](https://specstream.ai/data/businesses/b2b-medical-support-companies/united-states)
- [Sandblasting companies in the United States](https://specstream.ai/data/businesses/sandblasting-companies/united-states)
- [Jewelry and watches manufacturers in the United States](https://specstream.ai/data/businesses/jewelry-and-watches-manufacturers/united-states)
- [Cuban restaurants in the United States](https://specstream.ai/data/businesses/cuban-restaurants/united-states)
- [Window installers in the United States](https://specstream.ai/data/businesses/window-installers/united-states)
- [Plasterers in the United States](https://specstream.ai/data/businesses/plasterers/united-states)
